Evaluation of terguride in patients with Parkinson's disease.
D000328:Adult; D000368:Aged; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008090:Lisuride / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects
D004873:Ergolines; D011954:Receptors, Dopamine; C006208:dironyl; D008090:Lisuride